Literature DB >> 810238

Drug resistance in patients with pulmonary tuberculosis.

O T Cheung.   

Abstract

A review of the records of 984 patients admitted to hospital from 1970 through 1973 with bacteriologically proven pulmonary tuberculosis showed bacterial resistance to one or more antituberculosis drugs in 103 (10.5%). Among the patients who had had previous drug treatment for tuberculosis the prevalence of drug resistance was 20% in the Canadian-born patients and 69.4% in the recent immigrants. Among the patients who had had no previous drug treatment the prevalence of drug resistance (primary resistance) was 2.7% in Canadian-born patients but 11.4% in recent immigrants. Because of the higher prevalence of drug resistance among recent immigrants and the finding in recent years that increasingly more tuberculosis patients in Ontario are recent immigrants, drug resistance in this group is likely to assume even more importance in the future.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810238      PMCID: PMC1956689     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  The prevalence in Canada of drug-resistant tubercle bacilli in newly discovered untreated patients with tuberculosis.

Authors:  A R Armstrong
Journal:  Can Med Assoc J       Date:  1966-02-26       Impact factor: 8.262

2.  The influence of immigration on tuberculosis in Ontario.

Authors:  M J Ashley; T W Anderson; W H Le Riche
Journal:  Am Rev Respir Dis       Date:  1974-08

3.  Is primary drug-resistance to major antituberculous agents increasing?

Authors:  A G Jessamine; L Eidus; V Narasimhan
Journal:  Can J Public Health       Date:  1974 Sep-Oct
  3 in total
  2 in total

1.  Health problems of vietnamese refugees.

Authors:  J K Tan; K K Tan
Journal:  Can Fam Physician       Date:  1980-03       Impact factor: 3.275

2.  Tuberculosis--a review of 498 recent admissions to hospital.

Authors:  R S Goldstein; M Contreras; G A Craig; O T Cheung
Journal:  Can Med Assoc J       Date:  1982-03-01       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.